Clinical trial NCT06103006: Remote Physiotherapy to Protect Physical Health in Duchenne Muscular Dystrophy
Official title: Remote Physiotherapy to Protect Physical Health in Duchenne Muscular Dystrophy: Telerehabilitation
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Duchenne Muscular Dystrophy
Lead sponsor: Lokman Hekim Üniversitesi
Sponsor class: OTHER_GOV
First posted: 2023-10-26
Enrollment: 42
Sex: ALL
Minimum age (years): 5
Maximum age (years): 26
Standard ages: CHILD
ADULT
Accepts healthy volunteers: no
Allocation: NA
Intervention model: SINGLE_GROUP
Primary purpose: TREATMENT

Brief summary: Duchenne Muscular Dystrophy (DMD) is a progressive genetic neuromuscular disease characterized by progressive loss of motor function, respiratory failure, and cardiomyopathy required regular physiotherapy. With the outbreak of the pandemic rehabilitation centers that make up the weekly physiotherapy routine of children with disabilities have slowed down or even stopped their activities. So DMD who have additional diseases such as respiratory muscle weakness, spinal deformity, obesity, and cardiac dysfunction have also been negatively affected. The 'telerehabilitation' method, which is well planned and prepared for the abilities and needs of patients and caregivers, is seen as a good option at this point.

Studies, reporting the feasibility and safety of telerehabilitation in joint replacement, multiple sclerosis, and post-operative conditions, report that the length of stay was reduced, there was access to the same level of service regardless of the distance, and there was no travel cost. Despite these advantages, the framework and applicability of telerehabilitation programs have been investigated limited and not focused on effectiveness of telerehabilitation in patients with DMD.

According to the current knowledge, telerehabilitation in DMD is a subject that needs to be investigated in terms of its benefits. So, in this study, it was aimed to show the telerehabilitation's feasibility and its effects on performance level, endurance, fall frequency, pulmonary functions, and satisfaction level with the program in individuals with DMD.


Eligibility criteria: Inclusion Criteria:

* Able to communicate verbally and visually,
* Older than 5 years old

Exclusion Criteria:

* Individuals who had undergone any surgical operations in the past 6 months,
* Had a severe cognitive and breathing impairment,
* Using mechanical ventilator continually or intermittent,
* Having febrile infection

Primary outcomes:
measure: Endurance
timeFrame: Change from baseline at 8 weeks
measure: Modified Upper Extremity Performance Test
timeFrame: Change from baseline at 8 weeks
Secondary outcomes:
measure: 10 Meter (m) Walking Test
timeFrame: Change from baseline at 8 weeks
measure: Stand Up from the Supine Position Test
timeFrame: Change from baseline at 8 weeks
measure: Single Breath Count (SBC)
timeFrame: Change from baseline at 8 weeks
measure: Patient Satisfaction Survey
timeFrame: After 8 weeks
measure: Brooke Upper Extremity Scale
timeFrame: Change from baseline at 8 weeks
measure: Brooke Lower Extremity Scale
timeFrame: Change from baseline at 8 weeks
measure: Frequency of falling
timeFrame: Change from baseline at 8 weeks
Other outcomes:
Locations:
city: Ankara
country: Turkey
facility: Lokman Hekim University
Study officials:
References: